We develop, manufacture and sell medications within four specialties: hematology, rheumatology, oncology and endocrinology.

We focus on medications for patients with a large medical need. This category includes specialist drugs, which are mainly prescribed by clinical specialists and aimed at small well-defined patient groups. These often neglected and inadequately treated, less common diseases are attracting growing interest, in part because these medications generate value for the patient.
 

In 2008 we established our marketing organization in Europe, USA, Canada, Australia and New Zealand through the acquisition of three products. In addition, we have five other products, all marketed in the Nordic countries.

Customers include patients, healthcare providers, purchasers and pharmacy staff. The goal is to create a constant dialogue with customers and decision-makers and work with customized messages about the products.